DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Amicus Therapeutics Q4 EPS $(0.35) Misses $(0.27) Estimate, Sales $55.293M Beat $52.33M Estimate

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 14.63 percent increase over losses of $(0.41) per share

Benzinga · 03/02/2020 12:10

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 14.63 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $55.293 million which beat the analyst consensus estimate of $52.33 million by 5.66 percent. This is a 69.38 percent increase over sales of $32.644 million the same period last year.